Viewing StudyNCT00822809

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 9:10 PM
Last Modification Date: 2024-10-26 @ 10:00 AM
Study NCT ID: NCT00822809
Status: COMPLETED
Last Update Posted: 2012-10-03
First Post: 2008-12-23
Brief Title: CASIMAS Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers
Sponsor: Neovii Biotech
Organization: Neovii Biotech
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Malignant Ascites
Cancer
Neoplasms
Carcinoma
Keywords:
Name View
EpCAM View
Cancer View
Neoplasms View
Carcinoma View
Malignant Ascites View
Drug therapy View
Antineoplastic Protocols View
Immunotherapy View
Phase III View
trifunctional antibody View
monoclonal antibody View